Blog

The GAfPA Policy Blog explores health policy news, reports, initiatives and events that inform patient-centered care.

Blog Posts

Anemia affects approximately 2 billion people worldwide, or around 25% of the global population. But women bear a disproportionate burden of this condition. Healthcare systems and policymakers should prioritize blood health management, particularly for women who face unique risks. Thus, GAfPA joined a workshop at the European Parliament on “Reducing  Inequities in Women’s Access to Treatment and Care ” and contributed written comments to the forthcoming report on women’s health inequalities by the “MEPs for Women’s Health” Interest Group.
This week at the annual EULAR Congress, the recently launched Global Remission Coalition issued an update to the Value of Achieving Remission in Inflammatory Rheumatic Conditions Evidence Glossary, and the latest findings deepen the collective understanding of why remission matters – clinically, economically, and personally.
Healthy blood is integral to a healthy life. With more than three billion people affected by anemia, iron deficiency, blood loss and coagulopathy, blood health is increasingly recognized as a global public health concern. These conditions place a heavy burden on individual well-being and healthcare systems. To highlight new guidance published by the World Health Organization (WHO), GAfPA recently convened a diverse group of healthcare stakeholders to discuss the need to prioritize blood health and the implementation of Patient Blood Management (PBM).
Across the world more than 1.4 billion people are living with elevated lipoprotein(a), or Lp(a). Lp(a) is an inherited cardiovascular risk factor linked to heart attack, stroke and other serious cardiovascular conditions. Despite the prevalence, only 1–2% of the population gets tested for elevated Lp(a) levels.